Literature DB >> 17491002

In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.

M Shahid, M Singhai, A Malik, I Shukla, H M Khan, F Shujatullah, F Tahira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17491002     DOI： 10.1093/jac/dkm131

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Citrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance.

Authors:  M Shahid
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

2.  Bacteriological profile and antibiotic susceptibility of diabetic Foot infections at Ribat University hospital; a retrospective study from Sudan.

Authors:  Maram H Hamid; Ahmed H Arbab; Bashir A Yousef
Journal:  J Diabetes Metab Disord       Date:  2020-10-13

3.  Bacteriological and resistance profile in isolates from diabetic patients.

Authors:  Vinita Rawat; Monil Singhai; Ashok Kumar; Pawan Kumar Jha; Rajeev Goyal
Journal:  N Am J Med Sci       Date:  2012-11

4.  A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.

Authors:  Xiaojuan Xin; Li Jian; Xiaoying Xia; Bei Jia; Wenxiang Huang; Chongzhi Li; Changzheng Wang; Lixin Zhou; Xiuzhen Sun; Xinghuo Tang; Yijiang Huang; Yunkui Zhu; Weili Zhang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-12-09       Impact factor: 3.944
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.